Vitamin Shoppe (NYSE:VSI) Trading Up 5.6%

Vitamin Shoppe Inc (NYSE:VSI) was up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.80 and last traded at $3.80. Approximately 430,444 shares were traded during mid-day trading, a decline of 21% from the average daily volume of 543,104 shares. The stock had previously closed at $3.60.

Several equities analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Vitamin Shoppe from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 1st. ValuEngine lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, March 15th. Finally, Jefferies Financial Group assumed coverage on shares of Vitamin Shoppe in a research report on Monday, June 17th. They set a “hold” rating and a $4.00 price target for the company. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. Vitamin Shoppe currently has a consensus rating of “Hold” and an average price target of $7.92.

The company has a market cap of $94.52 million, a P/E ratio of 15.15 and a beta of 1.68. The business’s 50-day moving average price is $4.11. The company has a debt-to-equity ratio of 2.36, a quick ratio of 0.16 and a current ratio of 1.14.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, May 8th. The specialty retailer reported $0.21 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.24 by ($0.03). The company had revenue of $283.33 million for the quarter. Vitamin Shoppe had a net margin of 0.33% and a return on equity of 4.64%. As a group, sell-side analysts forecast that Vitamin Shoppe Inc will post 0.54 EPS for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Oregon Public Employees Retirement Fund bought a new position in Vitamin Shoppe during the fourth quarter valued at about $28,000. Investors Research Corp bought a new position in Vitamin Shoppe during the first quarter worth about $34,000. Optimum Investment Advisors bought a new position in Vitamin Shoppe during the first quarter worth about $35,000. Texas Permanent School Fund bought a new position in Vitamin Shoppe during the fourth quarter worth about $48,000. Finally, Macquarie Group Ltd. boosted its position in Vitamin Shoppe by 114.0% during the fourth quarter. Macquarie Group Ltd. now owns 10,136 shares of the specialty retailer’s stock worth $48,000 after purchasing an additional 5,400 shares during the period. Institutional investors own 88.97% of the company’s stock.

About Vitamin Shoppe (NYSE:VSI)

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Recommended Story: What is a conference call?

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.